Reevaluating clinical measurement tools in therapeutic trials: time to make a Rasch decision?

Affiliations

¹ From the University of Utah Health Care (A.G.S.), Salt Lake City; and University of Virginia (T.M.B.), Charlottesville. Gordon.smith@hsc.utah.edu.
² From the University of Utah Health Care (A.G.S.), Salt Lake City; and University of Virginia (T.M.B.), Charlottesville.

Editorial

A Gordon Smith et al. Neurology. 2014.

. 2014 Dec 2;83(23):2104-5.

doi: 10.1212/WNL.0000000000001058. Epub 2014 Nov 5.

¹ From the University of Utah Health Care (A.G.S.), Salt Lake City; and University of Virginia (T.M.B.), Charlottesville. Gordon.smith@hsc.utah.edu.
² From the University of Utah Health Care (A.G.S.), Salt Lake City; and University of Virginia (T.M.B.), Charlottesville.

No abstract available

Comment on

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group. Draak TH, et al. Neurology. 2014 Dec 2;83(23):2124-32. doi: 10.1212/WNL.0000000000001044. Epub 2014 Nov 5. Neurology. 2014. PMID: 25378677